Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

p15INK4b/CDKN2B Antibody, Novus Biologicals™
SDP

Rabbit Polyclonal Antibody

Supplier:  Novus Biologicals NBP238023

 View more versions of this product

Catalog No. NBP238023


Only null left
Add to Cart

Description

Description

p15INK4b/CDKN2B Polyclonal specifically detects p15INK4b/CDKN2B in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Specifications

Specifications

p15INK4b/CDKN2B
Polyclonal
Immunohistochemistry, Immunohistochemistry-Paraffin 1:50 - 1:200
P42772
CDKN2B
This antibody was developed against a recombinant protein corresponding to amino acids: MREENKGMPSGGGSDEGLASAAARGLVEKVRQLLEAG
0.1 mL
Cell Cycle and Replication
1030
Human
IgG
Immunohistochemistry, Immunohistochemistry (Paraffin)
Unconjugated
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide
CDK4I, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), cyclin-dependent kinases 4 and 6 binding protein, INK4BCDK4B inhibitor, MTS-2, MTS2CDK inhibitory protein, Multiple tumor suppressor 2, p14_CDK inhibitor, p14_INK4B, p14-INK4b, p15 CDK inhibitor, p15_INK4B, P15cyclin-dependent kinase 4 inhibitor B, p15INK4b, p15-INK4b, TP15
Rabbit
Affinity Purified
RUO
Primary
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.